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Background: Tear glands in the eyelids, meibomian 
glands, play a role in tear film production and tear film sta-
bilization. Diabetic patients often complain of dry eye and 
eye pain. Recently, there are new infrared (820nm) pho-
tography techniques to image meibomian glands easily in 
patients.
Purpose: To study meibomian glands in diabetic patients 
with dry eye.
Methods: A  retrospective chart review (2017-2019) of 
Type 2 Diabetes Mellitus (T2DM) patients and non-
diabetic patients with the diagnosis of “dry eye” in EHR 
(eClinicalworks, Westborough, MA) was performed. 
Infrared eyelid imaging (820 nm wavelength, Heidelberg 
Spectralis, Heidelberg, Germany) was taken. T2DM: 
Inclusion criteria: 1) HbA1c of > 5.7% who also had in-
frared eyelid imaging performed + 4 weeks of their HbA1c 
lab test results; 2)  the percentage loss of meibomian 
glands for each eye, then averaged, for each patient. 
Control: Inclusion criteria: 1)  non-diabetic patients; 
2)  HbA1c lab test results; 3)  infrared eyelid imaging 
was performed; 4)  percentage loss of meibomian glands 
was calculated for each eye, then averaged per patient. 
Exclusion criteria for both T2DM and Controls: younger 
than the age of 18 years old, older than 90 years old, no 
glaucoma topical medications, no eyelid surgery, no cor-
neal surgery, no conjunctival surgery.
Results: n=120 patients, Avg Age=69.6  years (sd=15.1, 
range 23-89  years). Diabetic patients: n=60 patients, 
Male=30, Female=30, Avg Age=65.1  years (sd=11.50, 
med=65.5, range 36-85  years). Controls: n=60 patients, 
Male=37, Female=23, Avg Age=54.1  years (sd=16.4, 
med=56.5, range 23-89  years). Meibomian gland loss: 
Diabetics=51.54%, Controls=11.29% (p<0.0001, t-test). 
Of the 60 DM patients: 35/37pts with HbA1c > 6.6% had 
greater loss of meibomian glands (>40%), compared to 
12/23 DM patients with HbA1c < 6.5%, p=0.0001.
Discussion: Loss of meibomian glands in diabetic 
patients have been recently investigated; however, its 
relationship to HbA1c as a possible biomarker has not 
been widely discussed in literature. In this small study, 
loss of meibomian glands occur more frequently with ele-
vated HbA1c, perhaps due to microischemia of the eyelids, 
thereby resulting in loss of meibomian glands.
Conclusion: Loss of meibomian glands may suggest a need 
for HbA1c testing and further monitoring of the patient’s 
diabetic condition. Infrared imaging of the eyelid may be 
useful in characterizing dry eye in diabetic patients.
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Background: Body dissatisfaction often contributes to 
the distress experienced by transgender and nonbinary 
individuals. However, limited data exist regarding body 
image in the pediatric age range.
Objective: To establish baseline ratings of body satisfac-
tion among gender-diverse youth prior to puberty blocking 
medication.
Methods: Subjects were recruited from the gender health 
clinic at Riley Hospital for Children beginning in January 
2018. Eligible subjects met clinical criteria for a puberty 
blocker, were treatment naïve, and were anticipated to be 
on a blocker alone for ≥ 1 year. We assessed self-reported 
body satisfaction at baseline using the Body Image Scale-
Gender Spectrum. Subjects rated various body parts on a 
scale of 1 (very satisfied) to 5 (very dissatisfied). For anal-
ysis, body parts were grouped into gendered features (pri-
mary sex, secondary sex, & neutral characteristics) and 
also body areas (appearance/hair/voice, head & neck, mus-
culoskeletal, hips, chest, & genitals/gonads).1
Results: Twenty subjects (mean age 12.0, range 8.4-14.0) 
were enrolled of whom 13 were transmasculine (TM) and 
7 were transfeminine (TF). TM subjects had a mean BMI 
percentile of 73.7% and height z-score of 0.50, with breast 
Tanner stage (TS) of II (n=2), III (n= 3), IV (n=3) and V 
(n=4). Estradiol levels ranged from <20-120 pg/mL and tes-
tosterone levels ranged from <10-38 ng/dL. TF subjects had 
a mean BMI percentile of 65.3% and height Z-score of 0.58, 
with testicular volumes of 5 cc (n=1), 6 cc (n=2), 9 cc (n=1), 
10 cc (n=1) and 15 cc (n=1). Testosterone levels ranged from 
<10-215 ng/dL and estradiol levels ranged from <5-31 pg/
mL. Among all subjects, mean satisfaction ratings for gen-
dered features were 4.45 (primary sex characteristics), 3.21 
(secondary sex characteristics), and 2.61 (neutral charac-
teristics). Mean satisfaction ratings for body areas were 
4.45 (genitals/gonads), 3.85 (chest), 3.23 (appearance/hair/
voice), 3.03 (hips), 2.83 (musculoskeletal), and 2.55 (head 
& neck). The only significant between-group difference in 
satisfaction was for the chest region, with TM subjects re-
porting higher dissatisfaction (4.35 vs 2.93, p <0.004).
Conclusion: The gender-diverse youth in our study re-
ported high degrees of dissatisfaction with their genitals/
gonads and, for TM subjects, their chest. In contrast, they 
reported generally neutral feelings toward many of their 
other body parts. To the best of our knowledge this is the 
youngest cohort of gender-diverse youth in whom body sat-
isfaction has been explored. Further studies of the effects 
of endocrine treatment on body image in gender-diverse 
youth are warranted, specifically as they relate to other 
measures of well-being.
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